fig1

Stereotactic body radiation therapy for primary liver tumors with adverse factors

Figure 1. Local control rate (top), progression-free survival rate (middle), and overall survival rate (bottom) for all patients in this study

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/